GoingToMeet

Enhancing Performance of Early Phase Drug Development Projects will look to examine the current state of project management approaches during pre-clinical to phase II and the improvements that can be made in planning, implementing, and controlling pharma project components. By developing these areas biopharma companies and project teams will be able to minimise the risks associated with a new drug's development, and better reach go/ no go decisions in both small and large molecule drugs.

Why Attend?
This conference will cover how to decide upon early phase research strategies, and the operational project management tools and techniques to be best used:

Improve strategic decision making to enable multiple project successes.

Minimise risks generated by advancing a compound's development

Learn how to execute projects involving varied early phase & remote stakeholders, both internally and externally.

Clarify project scope & team responsibilities to enable optimum allocation of resources.

Define project management tools and techniques to better leverage early stage research

Build effective project teams involving both internal and external resources.